BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10613654)

  • 1. Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation.
    Váradi K; Siekmann J; Turecek PL; Schwarz HP; Marder VJ
    Thromb Haemost; 1999 Dec; 82(6):1673-9. PubMed ID: 10613654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prothrombinase-based assay for detection of resistance to activated protein C.
    Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
    Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor Va, bound to microparticles released during platelet storage, is resistant to inactivation by activated protein C.
    Magdeleyns EJ; Keuren JF; Curvers J
    Transfusion; 2007 Oct; 47(10):1880-8. PubMed ID: 17880615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma factor V activation is prevented by activated protein C in the presence of phospholipid vesicles, not platelets.
    Solymoss S; Nguyen KT
    Thromb Haemost; 1993 Feb; 69(2):124-9. PubMed ID: 8456424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
    Safa O; Morrissey JH; Esmon CT; Esmon NL
    Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of activated protein C by platelets.
    Jane SM; Mitchell CA; Hau L; Salem HH
    J Clin Invest; 1989 Jan; 83(1):222-6. PubMed ID: 2910909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways.
    Hoekema L; Nicolaes GA; Hemker HC; Tans G; Rosing J
    Biochemistry; 1997 Mar; 36(11):3331-5. PubMed ID: 9116011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiolipin enhances protein C pathway anticoagulant activity.
    Fernández JA; Kojima K; Petäjä J; Hackeng TM; Griffin JH
    Blood Cells Mol Dis; 2000 Apr; 26(2):115-23. PubMed ID: 10753602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell-based model of thrombin generation.
    Roberts HR; Hoffman M; Monroe DM
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():32-8. PubMed ID: 16673264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
    De Smedt E; Wagenvoord R; Coen Hemker H
    Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation.
    Harker LA; Hanson SR; Kelly AB
    Thromb Haemost; 1997 Jul; 78(1):736-41. PubMed ID: 9198248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay.
    Curvers J; Christella M; Thomassen LG; de Ronde H; Bertina RM; Rosendaal FR; Tans G; Rosing J
    Thromb Haemost; 2002 Mar; 87(3):483-92. PubMed ID: 11924538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
    Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
    Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
    Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
    Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
    Shen L; He X; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):1030-6. PubMed ID: 9308749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiologie and cellular regulation of the protein C system].
    Vincenot A; Gaussem P
    Ann Biol Clin (Paris); 1997; 55(1):17-24. PubMed ID: 9099247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.